MCG
DWTX

McCollum Christoferson Group’s Dogwood Therapeutics DWTX Stock Holding History

McCollum Christoferson Group’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,340
Closed -$5.7K – 76
2024
Q3 		$5.7K Sell
1,340
-940
-41% -$4.87K ﹤0.01% 70
2024
Q2 		$12.3K Buy
2,280
+600
+36% +$5.19K ﹤0.01% 68
2024
Q1 		$20.1K Buy
1,680
+200
+14% +$2.25K 0.01% 63
2023
Q4 		$21.3K Buy
1,480
+148
+11% +$2.49K 0.01% 63
2023
Q3 		$30.8K Buy
1,332
+104
+8% +$3.62K 0.01% 67
2023
Q2 		$42.4K Buy
+1,228
New +$35K 0.01% 69

Other funds holding DWTX

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

McCollum Christoferson Group's DWTX Position: Q4 2024 in Review

McCollum Christoferson Group sold out of Dogwood Therapeutics (DWTX) in Q4 2024, closing a stake of 1,340 shares — an estimated $5.7K sold.

McCollum Christoferson Group first reported a position in DWTX in Q2 2023 and held it in 6 quarters. The position peaked at $42.4K in Q2 2023. 10 funds tracked by Wall St. Rank hold DWTX as of Q4 2024.

  • McCollum Christoferson Group reported no remaining Dogwood Therapeutics position as of Q4 2024 after selling out during the quarter.
  • McCollum Christoferson Group sold 1,340 Dogwood Therapeutics shares in Q4 2024, an estimated $5.7K.
  • McCollum Christoferson Group first reported a position in Dogwood Therapeutics in Q2 2023 and held it in 6 quarters.
  • McCollum Christoferson Group's Dogwood Therapeutics position peaked at $42.4K in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q4 2024.

Based on McCollum Christoferson Group's 13F filing for Q4 2024, filed 11 Feb 2025.